Sunlink Health Systems Inc SSY
We take great care to ensure that the data presented and summarized in this overview for SUNLINK HEALTH SYSTEMS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SSY
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny236KShares$216,7310.0% of portfolio
-
Acadian Asset Management LLC Boston, MA89.4KShares$82,2600.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA83.9KShares$77,2260.0% of portfolio
-
Granite Investment Partners, LLC74.5KShares$68,5440.0% of portfolio
-
Wittenberg Investment Management, Inc. Carlisle, MA51.6KShares$47,4640.02% of portfolio
-
State Street Corp Boston, MA42.6KShares$39,2260.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA36.6KShares$33,7120.0% of portfolio
-
Geode Capital Management, LLC Boston, MA35.1KShares$32,2480.0% of portfolio
-
Ubs Group Ag22.5KShares$20,7240.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX19.8KShares$18,2110.0% of portfolio
Latest Institutional Activity in SSY
Top Purchases
Top Sells
About SSY
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.
Insider Transactions at SSY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 14
2025
|
C Michael Ford |
SELL
Sale (or disposition) back to the issuer
|
Direct |
49,422
-100.0%
|
-
|
Aug 14
2025
|
Gene E Burleson |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,000
-100.0%
|
-
|
Aug 14
2025
|
Gene E Burleson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
81,601
-100.0%
|
-
|
Aug 14
2025
|
Steven J Baileys |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
281,600
-100.0%
|
-
|
Aug 14
2025
|
Steven J Baileys |
SELL
Sale (or disposition) back to the issuer
|
Direct |
551,244
-100.0%
|
-
|
Aug 14
2025
|
Mark J Stockslager |
SELL
Sale (or disposition) back to the issuer
|
Direct |
108,051
-100.0%
|
-
|
Aug 14
2025
|
Robert M Thornton Jr |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
559,562
-100.0%
|
-
|
Nov 24
2023
|
Howard E Turner Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.48%
|
$0
$0.97 P/Share
|
Oct 19
2023
|
Steven J Baileys |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
281,600
-100.0%
|
-
|
Oct 19
2023
|
Steven J Baileys |
SELL
Sale (or disposition) back to the issuer
|
Direct |
551,244
-100.0%
|
-
|
Oct 19
2023
|
Howard E Turner Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
28,219
-100.0%
|
-
|
Oct 19
2023
|
Howard E Turner Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
204,785
-100.0%
|
-
|
Oct 19
2023
|
Robert M Thornton Jr |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
559,562
-100.0%
|
-
|
Oct 19
2023
|
Mark J Stockslager |
SELL
Sale (or disposition) back to the issuer
|
Direct |
108,051
-100.0%
|
-
|
Oct 19
2023
|
C Michael Ford |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,422
-100.0%
|
-
|
Oct 19
2023
|
Gene E Burleson |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,000
-100.0%
|
-
|
Oct 19
2023
|
Gene E Burleson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
81,601
-100.0%
|
-
|
Sep 15
2023
|
C Michael Ford |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+5.72%
|
$0
$0.71 P/Share
|
Aug 16
2023
|
Gene E Burleson |
BUY
Grant, award, or other acquisition
|
Indirect |
10,000
+50.0%
|
-
|
Aug 16
2023
|
Gene E Burleson |
BUY
Grant, award, or other acquisition
|
Direct |
81,601
+50.0%
|
-
|
Last 12 Months Summary
Sale (or disposition) back to the issuer | 1.64M shares |
---|